Drug recall D-0789-2020
Product
Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.
Reason for recall
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
Lots and codes
Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.
Recall details
- Recalling firm
- AuroMedics Pharma LLC, East Windsor, NJ
- Quantity
- 100,080 bottles
- Distribution
- Nationwide in the U.S.
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 2, 2019
- Terminated
- November 22, 2022
Related products
- Moxifloxacin – drug information
- NDC 65862-840 Moxifloxacin · Moxifloxacin Hydrochloride 5 mg/mL · Aurobindo Pharma Limited